CellSight Diagnosis is a forward-thinking company founded by a dynamic team, including professionals from the fields of dentistry and oncology. The goal is to revolutionize leukemia diagnosis through advanced technology and comprehensive medical knowledge. They propose an innovative product that leverages artificial intelligence and image processing to enable early, accurate, and rapid diagnosis of acute leukemia. This software platform utilizes deep neural custom models to distinguish immature leukemic blasts from normal cells, facilitating precise diagnosis through microscopic image analysis. With a commitment to bridging the diagnostic gap and improving patient outcomes, CellSight Diagnosis is at the forefront of medical innovation, uniting expertise from diverse domains for a common purpose.
| Website | https://cellsightdiagnosis.com/ |
| Employees | 4 (3 on RocketReach) |
| Founded | 2024 |
| Industry | Medical and Diagnostic Laboratories |
| Keywords | Advanced Diagnostics, Disease Diagnostics, Cancer Diagnostics, Oncology Technology, Early Cancer Detection, Medical Technology, Digital Pathology, Hematology Diagnostics, Microscopy Technology, Pathology Imaging, Healthcare Technology, Precision Oncology, Cancer Research, Medical Imaging, Diagnostic Tools, Healthcare Innovation, Oncology Solutions |
Looking for a particular CellSight Diagnosis employee's phone or email?
Ardeshir Malekian is the CEO of CellSight Diagnosis.
3 people are employed at CellSight Diagnosis.